RENAL CELL CARCINOMA RECURRENT

This adverse event was reported 127 times

These drugs are most commonly taken by patients reporting RENAL CELL CARCINOMA RECURRENT:

# Drug Count
0 PEMBROLIZUMAB 35
1 NIVOLUMAB 16
2 CABOZANTINIB 15
3 LENVATINIB 12
4 PAZOPANIB HYDROCHLORIDE 11
5 AXITINIB 7
6 DEXAMETHASONE 6
7 DEXAMETHASONE 1.5 MG 6
8 EVEROLIMUS 6
9 MYCOPHENOLATE MOFETIL 6
See all common drugs associated with RENAL CELL CARCINOMA RECURRENT